Acute Lymphoblastic Leukemia News and Research

RSS
Acute lymphoblastic leukemia (ALL) is a cancer of the white blood cells, the cells in the body that normally fight infections. There are two main types of white blood cells-lymphoid cells and myeloid cells. ALL affects lymphoid cells.
First randomized clinical trial compares targeted therapies for acute lymphoblastic leukemia

First randomized clinical trial compares targeted therapies for acute lymphoblastic leukemia

Research collaboration reveals potential treatment option for incurable blood cancers

Research collaboration reveals potential treatment option for incurable blood cancers

Leukemia patients treated with common cancer drug have heightened risk of heart failure

Leukemia patients treated with common cancer drug have heightened risk of heart failure

New therapy shows dramatic effect against worst types of leukaemias

New therapy shows dramatic effect against worst types of leukaemias

IONTAS antibody for the treatment of B-Cell ALL receives approval for clinical trials

IONTAS antibody for the treatment of B-Cell ALL receives approval for clinical trials

Immunotherapy more effective than chemotherapy for children, young adults with relapsed B-ALL

Immunotherapy more effective than chemotherapy for children, young adults with relapsed B-ALL

New approach can improve the activity of CAR-T cells against blood and solid cancers

New approach can improve the activity of CAR-T cells against blood and solid cancers

Scientists discover new approach to treating incurable leukemia in children

Scientists discover new approach to treating incurable leukemia in children

Rutgers Cancer Institute researchers awarded $2.3 million in American Cancer Society grants

Rutgers Cancer Institute researchers awarded $2.3 million in American Cancer Society grants

Chemotherapy can cause drug-resistant mutations in pediatric ALL patients who relapse

Chemotherapy can cause drug-resistant mutations in pediatric ALL patients who relapse

TU Dresden scientists receive 4.5 million euros for fundamental research

TU Dresden scientists receive 4.5 million euros for fundamental research

Metabolite profiling during diagnosis helps identify poor treatment outcomes in ALL

Metabolite profiling during diagnosis helps identify poor treatment outcomes in ALL

Reduced exercise capacity linked to neurocognitive problems in survivors of childhood ALL

Reduced exercise capacity linked to neurocognitive problems in survivors of childhood ALL

Cytek Biosciences hits flow cytometry milestone: 40 color analysis from a single sample

Cytek Biosciences hits flow cytometry milestone: 40 color analysis from a single sample

Cytek Biosciences' flow cytometry system achieves 40 color analysis from a single sample

Cytek Biosciences' flow cytometry system achieves 40 color analysis from a single sample

Detecting neurocognitive change in children with acute lymphoblastic leukemia

Detecting neurocognitive change in children with acute lymphoblastic leukemia

Researchers explore risk of ALL in children with Down syndrome

Researchers explore risk of ALL in children with Down syndrome

Editing away cancer and HIV in China: win or lose?

Editing away cancer and HIV in China: win or lose?

Claims that cesarean sections increase the risk of autism are “highly unlikely”, say experts

Claims that cesarean sections increase the risk of autism are “highly unlikely”, say experts

Combination therapy could be a promising treatment for late-stage acute lymphoblastic leukemia

Combination therapy could be a promising treatment for late-stage acute lymphoblastic leukemia